Baxter Aktiengesellschaft
Baxter Aktiengesellschaft is named on 0 US grants and 4 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 0
- Published applications
- 4
- Inventors
- 11
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 1 |
| 2002 | 0 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
By publication year.
Technology areas
Share of 4 documents
Recent patents
No granted patents yet.
- Factor viii polypeptide having factor viii:c activity7 Apr 2005US 2005/0074836 A1
- 5' Nuclease nucleic acid amplification assay having an improved internal control26 Sep 2002US 2002/0137039 A1
- Methods for the preparation and use of internal standards for nucleic acid amplification assays1 Aug 2002US 2002/0102548 A1
- Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sample25 Oct 2001US 2001/0034020 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.